On November 29th, China's independent third-party financial service provider, Intelligent Future Co., Ltd. (hereinafter referred to as "Intelligent Future"), announced that it has signed a formal stock exchange transaction agreement with Bomei Group. According to the agreement, Intelligent Future will transfer its intelligent platforms, Rongshu Intelligent Technology (Beijing) Co., Ltd. (hereinafter referred to as "Rongshu Technology") and Shenzhen Xinbao Investment Management Co., Ltd. (hereinafter referred to as "Xinbao Investment"), valued at 1 billion yuan, to Bomei Group. This transaction is expected to be completed by the end of 2024. After the transaction is completed, Intelligent Future will become the major shareholder of Bomei Group, and Bomei Group will fully hold Rongshu Technology and Xinbao Investment.
Established in 1998, Intelligent Future is a third-party intelligent financial service platform in China, dedicated to providing consumers with full lifecycle insurance protection, wealth management, and value-added services. It also offers comprehensive technological support and integrated solutions for individual agents and sales organizations.
Rongshu Technology was founded in 2009, specializing in the development of digital and intelligent technologies in the fields of finance and insurance; Xinbao Investment has created a professional online insurance transaction and service platform "Baowang" integrating online and offline, which provides one-stop risk protection solutions for individuals, their families and SMEs with "technology, products and services".
It is reported that the main subsidiary of Bomei Group is Gansu Qilianshan Pharmaceutical Co., Ltd., which has developed into one of the leading providers of high-quality products and services in the global pharmaceutical industry.
Industry insiders believe that the collaboration between Intelligent Future and Bomei Group is conducive to creating a new development pattern of "medical, pharmaceutical, and insurance". Bomei's vast resources in the medical industry will bring more application scenarios for insurance products and services on intelligent platforms, further unleashing development potential and enabling artificial intelligence to move towards a broader stage.